Profil
Paul W.
K.
Rothemund was the founder of Palamedrix, Inc. and held the title of Head-Research & Development.
Aktive Positionen von Paul W. K. Rothemund
| Unternehmen | Position | Beginn |
|---|---|---|
Palamedrix, Inc.
 Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Palamedrix, Inc.
Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Commercial Services |
